Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05722444 · ClinicalTrials.gov registry record · NA
Sleep and Health Outcomes in Women With Heavy Menses
A NA study of Menstruation; Heavy, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05722444 is a NA study of Menstruation; Heavy that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05722444, a NA study of Menstruation; Heavy, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate subjective sleep over three consecutive menstrual cycles (menses and non-menses) in females reporting heavy menstrual bleeding. Following a baseline phase of one menstrual cycle, study subjects will use a standardized nighttime feminine product during menstruation for their second cycle. For the third cycle, subjects will continue to use the standardized menstrual product with behavioral modification that includes refraining from those sleep behaviors used to avoid nighttime menstrual leakage.
Conditions Studied
Interventions
- OTHER Nighttime Feminine Product
Study Locations (1)
Illinois
- Department of Dermatology, Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-02-06 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05722444
The ClinicalTrials.gov registry entry for NCT05722444 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menstruation; Heavy appearing as the primary indexed condition, and to 1 intervention - of which Nighttime Feminine Product is the first listed.
NCT05722444 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05722444 about?
NCT05722444 is a clinical study titled "Sleep and Health Outcomes in Women With Heavy Menses". This study will evaluate subjective sleep over three consecutive menstrual cycles (menses and non-menses) in females reporting heavy menstrual bleeding. Following a baseline phase of one menstrual cycle, study subjects will use a standardized nighttime feminine product during menstruation for their ...
What is the current status of trial NCT05722444?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-02-06. Estimated completion is 2024-05-31.
What conditions does trial NCT05722444 study?
This clinical trial studies the following conditions: Menstruation; Heavy.
What interventions are being tested in trial NCT05722444?
The interventions under investigation include: Nighttime Feminine Product (OTHER).
Who is sponsoring clinical trial NCT05722444?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05722444 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.